OKYO Pharma Limited (NASDAQ: OKYO) stock jumped 12.43% on Friday to $1.99 against a previous-day closing price of $1.77. With 0.19 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.25 million shares. During the session, the Biotechnology company that operates in wider Healthcare sector, reached to the highest price of $2.0800 whereas the lowest price it dropped to was $1.7700. The 52-week range on OKYO shows that it touched its highest point at $7.00 and its lowest point at $0.92 during that stretch. Beta for the stock currently stands at -0.04.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OKYO was up-trending over the past week, with a rise of 3.11%, but this was up by 17.06% over a month. The stock lost -37.22% in the past year, while it has gained 4.19% so far this year.
Float and Shares Shorts:
At present, 25.55 million OKYO shares are outstanding with a float of 16.88 million shares on hand for trading. On Aug 30, 2023, short shares totaled 0.28 million, which was 1.11% higher than short shares on Jul 30, 2023. In addition to Dr. Gary S. Jacob Ph.D. as the firm’s CEO & Exec. Director, Mr. Michael Paul Beck serves as its Founder.
Through their ownership of 0.08% of OKYO’s outstanding shares, institutional investors have minority control over the company. Other institutions hold — of OKYO, in contrast to — held by mutual funds. Shares owned by individuals account for –. As the largest shareholder in OKYO with 0.10% of the stake, Atlantic Private Wealth LLC holds 24,615 shares worth 24,615. A second-largest stockholder of OKYO, HSBC Global Asset Management, holds 11,933 shares, controlling over 0.05% of the firm’s shares. Goldman Sachs & Co. LLC is the third largest shareholder in OKYO, holding 0 shares or 0.00% stake.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OKYO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With OKYO analysts setting a high price target of $0.07 and a low target of $0.07, the average target price over the next 12 months is $0.07. Based on these targets, OKYO could drop -96.48% to reach the target high and fall by -96.48% to reach the target low. Reaching the average price target will result in a decline of -96.48% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.